The global Chinese patent medicine market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is mainly driven by the increasing demand for traditional medicines and rising awareness about their benefits among consumers. The increasing number of people suffering from chronic diseases such as diabetes, cancer, and cardiovascular diseases are also driving the growth of this market.
The global Chinese patent medicine market is segmented on the basis of type into syrup, liquid, and tablet; on the basis of application into online sales and offline sales; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). North America accounted for a share of 34% in 2018 in terms of revenue generated from Chinese patent medicines followed by Europe with a share of 27%. APAC accounted for a share 17% in 2018 followed by MEA with 14%.
- The Chinese patent medicine market is growing due to the increase in the number of people with chronic diseases.
- The Chinese patent medicine market is growing due to the increase in disposable income and a rise in consumer spending power.
- The Chinese patent medicine market is growing due to an aging population, which has increased demand for healthcare products and services, including traditional medicines such as patent medicines.
- The Chinese patent medicine market is growing due to an increase in government investment into research and development of new drugs, which will lead to more innovative treatments for chronic diseases that are not covered by Western pharmaceuticals or other treatments such as acupuncture or massage therapy.
Industry Growth Insights published a new data on “Chinese Patent Medicine Market”. The research report is titled “Chinese Patent Medicine Market research by Types (Syrup, Liquid, Tablet, Others), By Applications (Online Sales, Offline Sales), By Players/Companies Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd, Nanjing Pharmaceutical Industry (Group) Co., Ltd., North China Pharmaceutical Group Co., Ltd., Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Xinhualu Anti-Pharmaceutical Group Co., Ltd., Nanjing Pharmaceutical Co., Ltd, Chongqing Pharmaceutical Co., Ltd, Hangzhou Huadong Pharmaceutical Group Co., Ltd., Jiangxi Pharmaceutical Group Corporation, Shijiazhuang Pharmaceutical Group Co., Ltd., Northeast Pharmaceutical Group Co., Ltd.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chinese Patent Medicine Market Research Report
By Type
Syrup, Liquid, Tablet, Others
By Application
Online Sales, Offline Sales
By Companies
Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd, Nanjing Pharmaceutical Industry (Group) Co., Ltd., North China Pharmaceutical Group Co., Ltd., Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Xinhualu Anti-Pharmaceutical Group Co., Ltd., Nanjing Pharmaceutical Co., Ltd, Chongqing Pharmaceutical Co., Ltd, Hangzhou Huadong Pharmaceutical Group Co., Ltd., Jiangxi Pharmaceutical Group Corporation, Shijiazhuang Pharmaceutical Group Co., Ltd., Northeast Pharmaceutical Group Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Chinese Patent Medicine Market Report Segments:
The global Chinese Patent Medicine market is segmented on the basis of:
Types
Syrup, Liquid, Tablet, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online Sales, Offline Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shanghai Pharmaceutical (Group) Co., Ltd.
- China Pharmaceutical Group Corporation
- Guangzhou Pharmaceutical Group Co., Ltd.
- Tianjin Pharmaceutical Group Co., Ltd.
- Harbin Pharmaceutical Group Co., Ltd
- Nanjing Pharmaceutical Industry (Group) Co., Ltd.
- North China Pharmaceutical Group Co., Ltd.
- Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
- Taiji Group Co., Ltd.
- Xinhualu Anti-Pharmaceutical Group Co., Ltd.
- Nanjing Pharmaceutical Co., Ltd
- Chongqing Pharmaceutical Co., Ltd
- Hangzhou Huadong Pharmaceutical Group Co., Ltd.
- Jiangxi Pharmaceutical Group Corporation
- Shijiazhuang Pharmaceutical Group Co., Ltd.
- Northeast Pharmaceutical Group Co., Ltd.
Highlights of The Chinese Patent Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Syrup
- Liquid
- Tablet
- Others
- By Application:
- Online Sales
- Offline Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chinese Patent Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chinese patent medicine is a type of traditional Chinese medicine that uses herbs and other natural ingredients to treat medical conditions.
Some of the key players operating in the chinese patent medicine market are Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd, Nanjing Pharmaceutical Industry (Group) Co., Ltd., North China Pharmaceutical Group Co., Ltd., Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Xinhualu Anti-Pharmaceutical Group Co., Ltd., Nanjing Pharmaceutical Co., Ltd, Chongqing Pharmaceutical Co., Ltd, Hangzhou Huadong Pharmaceutical Group Co., Ltd., Jiangxi Pharmaceutical Group Corporation, Shijiazhuang Pharmaceutical Group Co., Ltd., Northeast Pharmaceutical Group Co., Ltd..
The chinese patent medicine market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chinese Patent Medicine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Chinese Patent Medicine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Chinese Patent Medicine Market - Supply Chain
4.5. Global Chinese Patent Medicine Market Forecast
4.5.1. Chinese Patent Medicine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Chinese Patent Medicine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Chinese Patent Medicine Market Absolute $ Opportunity
5. Global Chinese Patent Medicine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Chinese Patent Medicine Market Size and Volume Forecast by Type
5.3.1. Syrup
5.3.2. Liquid
5.3.3. Tablet
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Chinese Patent Medicine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Chinese Patent Medicine Market Size and Volume Forecast by Application
6.3.1. Online Sales
6.3.2. Offline Sales
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Chinese Patent Medicine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Chinese Patent Medicine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Chinese Patent Medicine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Chinese Patent Medicine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Chinese Patent Medicine Demand Share Forecast, 2019-2026
9. North America Chinese Patent Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Chinese Patent Medicine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Chinese Patent Medicine Market Size and Volume Forecast by Application
9.4.1. Online Sales
9.4.2. Offline Sales
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Chinese Patent Medicine Market Size and Volume Forecast by Type
9.7.1. Syrup
9.7.2. Liquid
9.7.3. Tablet
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Chinese Patent Medicine Demand Share Forecast, 2019-2026
10. Latin America Chinese Patent Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Chinese Patent Medicine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Chinese Patent Medicine Market Size and Volume Forecast by Application
10.4.1. Online Sales
10.4.2. Offline Sales
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Chinese Patent Medicine Market Size and Volume Forecast by Type
10.7.1. Syrup
10.7.2. Liquid
10.7.3. Tablet
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Chinese Patent Medicine Demand Share Forecast, 2019-2026
11. Europe Chinese Patent Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Chinese Patent Medicine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Chinese Patent Medicine Market Size and Volume Forecast by Application
11.4.1. Online Sales
11.4.2. Offline Sales
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Chinese Patent Medicine Market Size and Volume Forecast by Type
11.7.1. Syrup
11.7.2. Liquid
11.7.3. Tablet
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Chinese Patent Medicne Demand Share, 2019-2026
12. Asia Pacific Chinese Patent Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Chinese Patent Medicine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Chinese Patent Medicine Market Size and Volume Forecast by Application
12.4.1. Online Sales
12.4.2. Offline Sales
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Chinese Patent Medicine Market Size and Volume Forecast by Type
12.7.1. Syrup
12.7.2. Liquid
12.7.3. Tablet
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Chinese Patent Medicine Demand Share, 2019-2026
13. Middle East & Africa Chinese Patent Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Chinese Patent Medicine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Chinese Patent Medicine Market Size and Volume Forecast by Application
13.4.1. Online Sales
13.4.2. Offline Sales
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Chinese Patent Medicine Market Size and Volume Forecast by Type
13.7.1. Syrup
13.7.2. Liquid
13.7.3. Tablet
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Chinese Patent Medicine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Chinese Patent Medicine Market: Market Share Analysis
14.2. Chinese Patent Medicine Distributors and Customers
14.3. Chinese Patent Medicine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shanghai Pharmaceutical (Group) Co., Ltd.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. China Pharmaceutical Group Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Guangzhou Pharmaceutical Group Co., Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Tianjin Pharmaceutical Group Co., Ltd.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Harbin Pharmaceutical Group Co., Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nanjing Pharmaceutical Industry (Group) Co., Ltd.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. North China Pharmaceutical Group Co., Ltd.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Taiji Group Co., Ltd.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Xinhualu Anti-Pharmaceutical Group Co., Ltd.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nanjing Pharmaceutical Co., Ltd
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Chongqing Pharmaceutical Co., Ltd
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Hangzhou Huadong Pharmaceutical Group Co., Ltd.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Jiangxi Pharmaceutical Group Corporation
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Shijiazhuang Pharmaceutical Group Co., Ltd.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Northeast Pharmaceutical Group Co., Ltd.
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
